Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study

Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study

Abstract Background Metaplastic breast cancer remains poorly characterized given its rarity and heterogeneity. The majority of metaplastic breast cancers demonstrate a phenotype of triple-negative breast cancer; however, differences in clinical outcomes between metaplastic breast cancer and triple-n...

Full description

Bibliographic Details
Main Authors: Evan Morgan, Anupama Suresh, Akaansha Ganju, Daniel G. Stover, Robert Wesolowski, Sagar Sardesai, Anne Noonan, Raquel Reinbolt, Jeffrey VanDeusen, Nicole Williams, Mathew A. Cherian, Zaibo Li, Gregory Young, Marilly Palettas, Julie Stephens, Joseph Liu, Amanda Luff, Bhuvaneswari Ramaswamy, Maryam Lustberg
Format: Article
Language:English
Published: BMC 2020-01-01
Series:World Journal of Surgical Oncology
Subjects:
Metaplastic breast cancer
Clinical outcomes
Distant disease-free survival
Overall survival
Triple-negative breast cancer
Immune markers
Online Access:https://doi.org/10.1186/s12957-019-1780-8

Internet

https://doi.org/10.1186/s12957-019-1780-8

Similar Items